written on 07.03.2014

EU suggests new warning for same sleeping pill that landed a Kennedy before a jury


Sleep drugs have been the root of plenty of safety worries over the years, especially when it comes to driving while under their influence. Now, just a week after the wrap of one of the highest-profile cases to revolve around Ambien generic zolpidem–Kerry Kennedy's–the European Medicines Agency's Pharmacovigilance Risk Assessment Committee is recommending updates to its product information to underscore the drug's associated risks.

Latest Reports